BioStem Technologies (BSEM) Earnings Date & Reports

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the bodyâ€™s innate biology to repair or reverse damage caused by a broad range of degenerative diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BSEM is expected to report earnings to fall 45.74% to 50 cents per share on May 20

BioStem Technologies BSEM Stock Earnings Reports

Q1'25

Est.

$0.51

Q4'24

Beat

by $0.56

Q3'24

Beat

by $0.06

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.03

The last earnings report on April 14 showed earnings per share of 93 cents, beating the estimate of 37 cents. With 74.51K shares outstanding, the current market capitalization sits at 244.53M.

View a ticker or compare two or three

Compare

BSEM